Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804505 · ClinicalTrials.gov registry record · NA
Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study
A NA study of Hypersensitivity and Corneal Disease, sponsored by SynergEyes.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 8
- Study locations
NCT00804505 is a NA study of Hypersensitivity and Corneal Disease that has completed, run by SynergEyes. The registered enrollment target is 98 participants, below the 172-participant average among 8 other Hypersensitivity trials with a reported enrollment target (43% lower). The trial reports 8 study locations across 7 states.
The verdict
NCT00804505, a NA study of Hypersensitivity and Corneal Disease, has completed, sponsored by SynergEyes.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of the study is to demonstrate that the SynergEyes SA Hybrid Contact Lens clinical performance is substantially equivalent to that of the SynergEyes A Hybrid Lens when studied: * within the corresponding range of lens powers * in a population randomized within multiple investigational sites * with a study ration of 2/1 test vs control lenses * for a duration of 90 days.
Conditions Studied
Interventions
- DEVICE SynergEyes Hybrid (petrafocon A hem-larafilcon A) Hybrid Contact Lens
- DEVICE SynergEyes Hybrid (paflufocon D hem-iberfilcon A) Contact Lens
Study Locations (8)
California
- Carmel Mountain Vision Care - San Diego
- Silicon Valley Eye Physicians - Sunnyvale
Massachusetts
- Casazza Optometric Group - Andover
Michigan
- Vision Care Associates - East Lansing
Ohio
- Western Reserve Vision Care, Inc. - Beachwood
Rhode Island
- Dr. Karambelas & Associates - Providence
Tennessee
- Primary Eyecare Group P.C. - Brentwood
Wyoming
- Snowy Range Vision Center - Laramie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00804505
The ClinicalTrials.gov registry entry for NCT00804505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 172-participant average among 8 other Hypersensitivity trials with a reported enrollment target (43% lower). The listed sponsor is SynergEyes, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypersensitivity appearing as the primary indexed condition, and to 2 interventions - of which SynergEyes Hybrid (petrafocon A hem-larafilcon A) Hybrid Contact Lens is the first listed.
NCT00804505 reports 8 study locations spanning 7 distinct geographic areas - top geographies include California, Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT00804505 about?
NCT00804505 is a clinical study titled "Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study". The purpose of the study is to demonstrate that the SynergEyes SA Hybrid Contact Lens clinical performance is substantially equivalent to that of the SynergEyes A Hybrid Lens when studied: * within the corresponding range of lens powers * in a population randomized within multiple investigational s...
What is the current status of trial NCT00804505?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2008-06. Estimated completion is 2008-12.
What conditions does trial NCT00804505 study?
This clinical trial studies the following conditions: Hypersensitivity, Corneal Disease.
What interventions are being tested in trial NCT00804505?
The interventions under investigation include: SynergEyes Hybrid (petrafocon A hem-larafilcon A) Hybrid Contact Lens (DEVICE), SynergEyes Hybrid (paflufocon D hem-iberfilcon A) Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT00804505?
This trial is sponsored by SynergEyes, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00804505 being conducted?
This trial has 8 study locations across California, Massachusetts, Michigan, Ohio, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypersensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity
COMPLETED · NA
-
Asthma Data Innovation Demonstration Project
COMPLETED · NA
-
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
RECRUITING
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
-
Oral Bacteria and Allergic Disease in Children
COMPLETED
-
Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.